APA (7th ed.) Citation

SS, S., C, C., JY, J., S, V. W., SK, M., BA, D., . . . GR, O. (2025). FDA-AACR Strategies for Optimizing Dosages for Oncology Drug Products: Selecting Optimized Dosages for Registrational Trials. Clinical cancer research : an official journal of the American Association for Cancer Research, 31(23), 4891. https://doi.org/10.1158/1078-0432.CCR-25-0098

Chicago Style (17th ed.) Citation

SS, Shord, Chen C, Jin JY, Van Wart S, Martin SK, Davidson BA, Liu J, LoRusso PM, and Oxnard GR. "FDA-AACR Strategies for Optimizing Dosages for Oncology Drug Products: Selecting Optimized Dosages for Registrational Trials." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 31, no. 23 (2025): 4891. https://doi.org/10.1158/1078-0432.CCR-25-0098.

MLA (9th ed.) Citation

SS, Shord, et al. "FDA-AACR Strategies for Optimizing Dosages for Oncology Drug Products: Selecting Optimized Dosages for Registrational Trials." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 31, no. 23, 2025, p. 4891, https://doi.org/10.1158/1078-0432.CCR-25-0098.